Transcriptome analysis of non-small cell lung cancer and genetically matched adjacent normal tissues identifies novel prognostic marker genes

[1]  Genevera I. Allen,et al.  TCGA2STAT: simple TCGA data access for integrated statistical analysis in R , 2016, Bioinform..

[2]  H. Fuchs,et al.  MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[3]  X. Lang,et al.  AGER genetic polymorphisms increase risks of breast and lung cancers. , 2015, Genetics and molecular research : GMR.

[4]  X. Bian,et al.  Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types , 2015, Scientific Reports.

[5]  Kwok-Kin Wong,et al.  Non-small-cell lung cancers: a heterogeneous set of diseases , 2014, Nature Reviews Cancer.

[6]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[7]  S. Salzberg,et al.  StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.

[8]  Chirayu Pankaj Goswami,et al.  PROGgeneV2: enhancements on the existing database , 2014, BMC Cancer.

[9]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[10]  Jae Cheol Lee,et al.  RNA sequencing identifies novel markers of non-small cell lung cancer. , 2014, Lung cancer.

[11]  Hong-bing Liu,et al.  Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer , 2014, BMC Cancer.

[12]  Mary B. Daly,et al.  BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer , 2013 .

[13]  A. Gazdar,et al.  The pivotal role of pathology in the management of lung cancer. , 2013, Journal of thoracic disease.

[14]  E. Chen,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[15]  John D. Minna,et al.  Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations , 2013, Molecular Cancer Research.

[16]  Yoo Jin Jung,et al.  The transcriptional landscape and mutational profile of lung adenocarcinoma , 2012, Genome research.

[17]  Mats Lambe,et al.  Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation , 2012, Clinical Cancer Research.

[18]  Angela N. Brooks,et al.  Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.

[19]  Kenneth K. Lopiano,et al.  RNA-seq: technical variability and sampling , 2011, BMC Genomics.

[20]  E. Brambilla,et al.  The evolving role of histology in the management of advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Kakajan Komurov,et al.  Patterns of human gene expression variance show strong associations with signaling network hierarchy , 2010, BMC Systems Biology.

[22]  Hideaki Sugawara,et al.  The Sequence Read Archive , 2010, Nucleic Acids Res..

[23]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[24]  Sandrine Dudoit,et al.  Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments , 2010, BMC Bioinformatics.

[25]  L. Sequist,et al.  Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung Cancer , 2009, Journal of Thoracic Oncology.

[26]  Gudrun Schleiermacher,et al.  Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma , 2008, Nature.

[27]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[28]  Timothy B. Stockwell,et al.  The Diploid Genome Sequence of an Individual Human , 2007, PLoS biology.

[29]  Yi Zhang,et al.  Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. , 2006, Cancer research.

[30]  David Harrington,et al.  Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. , 2002, The New England journal of medicine.

[31]  Liquid Biopsies.  Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.

[32]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[33]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[34]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.